Hybrid deep model for predicting anti-cancer drug efficacy in colorectal cancer patients

被引:0
|
作者
Karthikeyan, A. [1 ]
Jothilakshmi, S. [1 ]
Suthir, S. [2 ]
机构
[1] Annamalai Univ, Dept Informat Technol, Chidambaram 608002, Tamil Nadu, India
[2] Amrita Vishwa Vidyapeetham, Dept Comp Sci & Engn, Amrita Sch Comp, Chennai, Tamil Nadu, India
关键词
Drug efficacy prediction; Recursive Feature Elimination with Hybrid Machine Learning mechanism; Gini impurity; Updated Rectified Linear Unit-Deep Convolutional Neural Network; Colorectal Cancer;
D O I
10.3233/WEB-230260
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Cancers are genetically diversified, so anticancer treatments have different levels of efficacy on people due to genetic differences. The main objective of this work is to predict the anticancer drug efficiency for colorectal cancer patients to reduce the mortality rates and provides immune energy for the patients. This paper proposes a novel anti-cancer drug efficacy system in colorectal cancer patients. The input data gene is normalized with the Min-Max normalization technique that normalizes the data in distinct scales. Subsequently, proposes an improved entropy-based feature to evaluate the uncertainty distribution of data, in which it induces weight to overcome the issue of computational complexity. Along with this feature, a correlation-based feature and statistical features are also retrieved. Subsequently, proposes a Recursive Feature Elimination with Hybrid Machine Learning (RFEHML) mechanism for selecting the appropriate feature set by eliminating the recursive features with the aid of hybrid Machine Learning strategies that combine decision tree and logistic regression. Also, the Gini impurity is employed for ranking the feature and selecting the maximum importance score by eliminating the least acquired importance score. Further, proposes a hybrid model for predicting the drug efficiency with the trained feature set. The hybrid model comprises of Long Short-Term Memory (LSTM) and Updated Rectified Linear Unit-Deep Convolutional Neural Network (UReLU-DCNN) model, in which DCNN is modified by updating the activation function at the fully connected layer. Consequently, the learned feature predicts the drug efficacy of anti-cancer in colorectal cancer patients by determining whether the patient is a responder or non- responder of the drug. Finally, the performance of the proposed RFEHML model is compared with other traditional approaches. It is found that the developed method has higher accuracy for each learning percentage, with values of 60LP = 92.48%, 70LP = 94.28%, 80LP = 95.24%, and 90LP = 96.86%, respectively.
引用
收藏
页码:359 / 380
页数:22
相关论文
共 50 条
  • [1] DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
    Preuer, Kristina
    Lewis, Richard P. I.
    Hochreiter, Sepp
    Bender, Andreas
    Bulusu, Krishna C.
    Klambauer, Guenter
    BIOINFORMATICS, 2018, 34 (09) : 1538 - 1546
  • [2] The risk of anti-cancer related cardiotoxicities in colorectal cancer patients following different anti-cancer drug treatments
    Wen, Pin-Chun
    Ciou, Wan-Jyun
    Ho, Chin-Chin
    Yang, Chen-Chang
    CLINICAL TOXICOLOGY, 2020, 58 (04) : 337 - 338
  • [3] The risk of anti-cancer drugs related cardiotoxicities in colorectal cancer patients following different anti-cancer drug treatments
    Wen, Pin-Chun
    Ciou, Wan-Jyun
    Ho, Chin-Chin
    Yang, Chen-Chang
    CLINICAL TOXICOLOGY, 2019, 57 (12) : 1182 - 1183
  • [4] Correlation of anti-cancer drug structure to efficacy
    Turner, John
    Chalk, Stuart
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [5] Establishment of a novel model for anti-cancer drug resistance using human colorectal cancer organoid
    Usui, Tatsuva.
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S95 - S95
  • [6] Anti-cancer activity of nitrones in the ApcMin/+ model of colorectal cancer
    Floyd, Robert A.
    Towner, Rheal A.
    Wu, Dee
    Abbott, Andrew
    Cranford, Rebecca
    Branch, Dan
    Guo, Wei-Xing
    Foster, Steven B.
    Jones, Inna
    Alam, Rajib
    Moore, Danny
    Allen, Toby
    Huycke, Mark
    FREE RADICAL RESEARCH, 2010, 44 (01) : 108 - 117
  • [7] Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation
    Li, Zheng
    Yin, Dong-Feng
    Wang, Wei
    Zhang, Xin-Wei
    Zhou, Li-Jiang
    Yang, Jun
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (32) : 9869 - 9877
  • [8] Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation
    Zheng Li
    Dong-Feng Yin
    Wei Wang
    Xin-Wei Zhang
    Li-Jiang Zhou
    Jun Yang
    World Journal of Clinical Cases, 2021, (32) : 9869 - 9877
  • [9] Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response
    Su, Ran
    Liu, Xinyi
    Wei, Leyi
    Zou, Quan
    METHODS, 2019, 166 : 91 - 102
  • [10] Predicting anti-cancer drug combination responses with a temporal cell state network model
    Sarmah, Deepraj
    Meredith, Wesley O.
    Weber, Ian K.
    Price, Madison R.
    Birtwistle, Marc R.
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (05)